• EAACI Biologicals Guidelines—Recommendations for Severe Asthma
• EAACI Biologicals Guidelines – Omalizumab for the treatment of chronic spontaneous urticaria in children and in adults
• EAACI Biologicals Guidelines- Dupilumab for children and adults with moderate-to-severe atopic dermatitis
• Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines